Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Cady, Ryan J ^a   Glenn, Joseph R ^a   Smith, Kael M ^a   Durham, Paul L ^a  

^a MISSOURI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS; PURINERGIC P2X3 RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CELL STIMULATION; CENTRAL NERVOUS SYSTEM SENSITIZATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOLECULAR PATHOLOGY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; TEMPOROMANDIBULAR JOINT DISORDER; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION; ANIMAL; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSORY RECEPTOR; SPRAGUE DAWLEY RAT;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CENTRAL NERVOUS SYSTEM SENSITIZATION; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SENSORY RECEPTOR CELLS; TEMPOROMANDIBULAR JOINT DISORDERS; TRIGEMINAL GANGLION;

EID: 82655162516     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-94     Document Type: Article

References (58)

1. Sessle BJ. Neural mechanisms and pathways in craniofacial pain. Can J Neurol Sci 1999, 26(Suppl 3):S7-11.
2. Sessle BJ. Peripheral and central mechanisms of orofacial pain and their clinical correlates. Minerva Anestesiol 2005, 71:117-136.
3. Okeson J. Management of Temporomandibular Disorders and Occlusion 2008, St. Louis, MO, 6.
4. Bonjardim LR, Lopes-Filho RJ, Amado G, Albuquerque RL, Goncalves SR. Association between symptoms of temporomandibular disorders and gender, morphological occlusion, and psychological factors in a group of university students. Indian J Dent Res 2009, 20:190-194.
5. Shankland W. The trigeminal nerve. Part IV: the mandibular division. Journal of Craniomandibular Practice 2001, 19:153-161.
6. Ji RR. Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr Drug Targets Inflamm Allergy 2004, 3:299-303.
7. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, Wei F, Dubner R, Ren K. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. The Journal of neuroscience: the official journal of the Society for Neuroscience 2007, 27:6006-6018.
8. Kopp S. Neuroendocrine, immune, and local responses related to temporomandibular disorders. J Orofac Pain 2001, 15:9-28.
9. Sessle B. New insights into peripheral chemical mediators of temporomandibular pain and inflammation. J Orofac Pain 2001, 15:5.
10. Kido M, Kiyoshima T, Kondo T, Ayasaka N, Moroi R, Terada Y, Tanaka T. Distribution of substance P and calcitonin gene-related peptide-like immunoreactive nerve fibers in the rat temporomandibular joint. J Dent Res 1993, 72:592-598.
11. Uddman R, Grunditz T, Kato J, Sundler F. Distribution and origin of nerve fibers in the rat temporomandibular joint capsule. Anat Embryol 1998, 197:273-282.
12. Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special considerations to rheumatoid arthritis. J Orofac Pain 1995, 9:215-225.
13. Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Relation between intra-articular temperature of the arthritic temporomandibular joint and presence of calcitonin gene-related peptide in the joint fluid. A clinical study. Acta Odontol Scand 1993, 51:285-291.
14. Ottosson A, Edvinsson L. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 1997, 17:166-174.
15. Seybold V. The Role of Peptides in Central Sensitization. Handbook of Exp Pharma 2009, 194:451-491.
16. Seybold V, McCarson K, Mermelstein P, Groth R, Abrahams J. Calcitonin gene-related peptide regulates expression of neurokinin1 receptors by rat spinal neurons. The Journal of Neuroscience 2003, 23:1816-1824.
17. Hucho T, Levine JD. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007, 55:365-376.
18. Li D, Ren Y, Xu X, Zou X, Fang L, Lin Q. Sensitization of primary afferent nociceptors induced by intradermal capsaicin involves the peripheral release of calcitonin gene-related Peptide driven by dorsal root reflexes. J Pain 2008, 9:1155-1168.
19. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 2008, 507:1277-1299.
20. Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 2007, 47:1008-1023.
21. Van Rossum D, Hanisch U, Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 1997, 21:649-678.
22. Hughes SR, Brain SD. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Br J Pharmacol 1991, 104:738-742.
23. Edvinsson L, Nilsson E, Jansen-Olesen I. Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 2007, 150:633-640.
24. Jang JH, Nam TS, Paik KS, Leem JW. Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat. Neurosci Lett 2004, 360:129-132.
25. Zhang L, Hoff A, Wimalawansa S, Cote G, Gagel R, Westlund K. Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain 2001, 89:265-273.
26. Cady RJ, Hirst JJ, Durham PL. Dietary grape seed polyphenols repress neuron and glia activation in trigeminal ganglion and trigeminal nucleus caudalis. Mol Pain 2010, 6:91.
27. Shinoda M, Ozaki N, Asai H, Nagamine K, Sugiura Y. Changes in P2X3 receptor expression in the trigeminal ganglion following monoarthritis of the temporomandibular joint in rats. Pain 2005, 116:42-51.
28. Ji RR, Gereau R, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60:135-148.
29. Sluka KA, Price MP, Breese NM, Stucky CL, Wemmie JA, Welsh MJ. Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 2003, 106:229-239.
30. Ji R, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60:135-148.
31. Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch Oral Biol 1995, 40:127-135.
32. Holmlund A, Ekblom A, Hansson P, Lind J, Lundenberg T, Theodorsson E. Concentration of neuropeptide substance - P, Neurokinin A, calcitonin gene related peptide, neuropeptide Y and vasoactive intestinal polypeptide in the synovial fluid of the -human temporomandibular joint. Int J Oral Maxillofac Surg 1991, 20:228-231.
33. Geppetti P, Del Bianco E, Patacchini R, Santicoli P, Maggi C, Tramontana M. Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves; mechanism of action and biological response. Neurosci 1991, 41:295-301.
34. Cheng J, Ji R. Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res 2008, 33:1970-1978.
35. Takeda M, Takahashi M, Matsumoto S. Contribution of the activation of satellite glia in sensory ganglia to pathological pain. Neurosci Biobehav Rev 2009, 33:784-792.
36. Cheng JK, Ji RR. Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res 2008, 33:1970-1978.
37. Crown ED, Ye Z, Johnson KM, Xu GY, McAdoo DJ, Hulsebosch CE. Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp Neurol 2006, 199:397-407.
38. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. The Journal of neuroscience: the official journal of the Society for Neuroscience 2003, 23:1026-1040.
39. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004, 45:89-95.
40. Suter MR, Wen YR, Decosterd I, Ji RR. Do glial cells control pain?. Neuron Glia Biol 2007, 3:255-268.
41. Ren K. Emerging role of astroglia in pain hypersensitivity. Jpn Dent Sci Rev 2010, 46:86.
42. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002, 82:981-1011.
43. Han JS, Li W, Neugebauer V. Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. The Journal of neuroscience: the official journal of the Society for Neuroscience 2005, 25:10717-10728.
44. Fitzgerald EM, Okuse K, Wood JN, Dolphin AC, Moss SJ. cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J Physiol 1999, 516(Pt 2):433-446.
45. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau R. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35:721-731.
46. Aley KO, Levine JD. Role of protein kinase A in the maintenance of inflammatory pain. The Journal of neuroscience: the official journal of the Society for Neuroscience 1999, 19:2181-2186.
47. Malmberg AB, Brandon EP, Idzerda RL, Liu H, McKnight GS, Basbaum AI. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. The Journal of neuroscience: the official journal of the Society for Neuroscience 1997, 17:7462-7470.
48. Burnstock G. Purinergic signalling--an overview. Novartis Found Symp 2006, 276:26-48. discussion 48-57, 275-281.
49. Burnstock G, Wood JN. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 1996, 6:526-532.
50. Hamilton SG, McMahon SB. ATP as a peripheral mediator of pain. J Auton Nerv Syst 2000, 81:187-194.
51. Staikopoulos V, Sessle BJ, Furness JB, Jennings EA. Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons. Neuroscience 2007, 144:208-216.
52. Jarvis MF. Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain. Expert Opin Ther Targets 2003, 7:513-522.
53. Burnstock G. P2X receptors in sensory neurones. Br J Anaesth 2000, 84:476-488.
54. Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, Van Biesen T, Cartmell J, Bianchi B, et al. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 2002, 99:17179-17184.
55. Oliveira MC, Pelegrini-da-Silva A, Tambeli CH, Parada CA. Peripheral mechanisms underlying the essential role of P2X3,2/3 receptors in the development of inflammatory hyperalgesia. Pain 2009, 141:127-134.
56. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 2008, 372:2115-2123.
57. Cady RJ, Durham PL. Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neurons. Brain Res 2010,
58. Garrett FG, Durham PL. Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation. Neuron Glia Biol 2008, 4:295-306.